Inhibition of Ca2+ permeable channel TRPV2 activity ameliorates muscular dysgenesis in cardiomyopathic animal models

被引：0
|
作者：
Iwata, Yuko [1 ]
Wakabayashi, Shigeo [1 ]
机构：
[1] Natl Cardiovasc Ctr, Res Inst, Dept Mol Physiol, Osaka 5658565, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2010年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：127P / 127P
页数：1
相关论文
共 50 条
  • [1] Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models
    Iwata, Yuko
    Katanosaka, Yuki
    Arai, Yuji
    Shigekawa, Munekazu
    Wakabayashi, Shigeo
    HUMAN MOLECULAR GENETICS, 2009, 18 (05) : 824 - 834
  • [2] Amelioration of muscular dystrophy by dominant-negative inhibition of Ca2+ permeable channel TRPV2
    Iwata, Yuko
    Wakabayashi, Shigeo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 96P - 96P
  • [3] Development of Ca2+ permeable channel (TRPV2) inhibitors potentially available for therapy of muscular dystrophy
    Iwata, Yuko
    Wakabayashi, Shigeo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 165P - 165P
  • [4] Ca2+-permeable channel TRPV2 as a promising therapeutic target for muscular dystrophy and cardiomyopathy
    Iwata, Y.
    Wakabayashi, S.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 653 - 653
  • [5] AMELIORATION OF MUSCULAR DYSTROPHY BY DOMINANT-NEGATIVE INHIBITION OF Ca2+ INFLUX VIA TRPV2
    Iwata, Yuko
    Wakabayashi, Shigeo
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 397 - 397
  • [6] Inhibition of sarcolemmal accumulation of TRPV2 prevents progression of dilated cardiomyopathy in animal models
    Iwata, Yuko
    Otake, Hitomi
    Kamauchi, Shinya
    Wakabayashi, Shigeo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 133P - 133P
  • [7] Molecular properties of Ca2+ transport through TRPV2 channel: a molecular dynamics simulations study
    Alipour, Mozhgan
    Hajipour-Verdom, Behnam
    Abdolmaleki, Parviz
    Javan, Mohammad
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (09): : 3892 - 3899
  • [8] TRPV2 inhibition therapy can be effective for cardiomyopathy of muscular dystrophy
    Matsumura, T.
    Matsui, M.
    Iwata, Y.
    Asakura, M.
    Saito, T.
    Fujimura, H.
    Sakoda, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 423 - 423
  • [9] TRPV2 inhibition therapy can be effective for cardiomyopathy of muscular dystrophy
    Matsumura, T.
    Matsui, M.
    Iwata, Y.
    Asakura, M.
    Saito, T.
    Fujimura, H.
    Sakoda, S.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S204 - S205
  • [10] TRPV2 Regulates Cardiomyocyte Function via Altering Ca2+ Cycling
    Gao, Xiaoqian
    Koch, Sheryl
    Jiang, Min
    Robbins, Nathan
    Cai, Wenfeng
    Varma, Priyanka
    Tranter, Michael
    Jones, W. Keith
    Wang, Hong-Sheng
    Rubinstein, Jack
    CIRCULATION RESEARCH, 2012, 111 (04)
12345